Cargando…
Alzheimer’s disease-like APP processing in wild-type mice identifies synaptic defects as initial steps of disease progression
BACKGROUND: Alzheimer’s disease (AD) is the most frequent form of dementia in the elderly and no effective treatment is currently available. The mechanisms triggering AD onset and progression are still imperfectly dissected. We aimed at deciphering the modifications occurring in vivo during the very...
Autores principales: | Audrain, Mickael, Fol, Romain, Dutar, Patrick, Potier, Brigitte, Billard, Jean-Marie, Flament, Julien, Alves, Sandro, Burlot, Marie-Anne, Dufayet-Chaffaud, Gaelle, Bemelmans, Alexis-Pierre, Valette, Julien, Hantraye, Philippe, Déglon, Nicole, Cartier, Nathalie, Braudeau, Jérome |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4709894/ https://www.ncbi.nlm.nih.gov/pubmed/26759118 http://dx.doi.org/10.1186/s13024-016-0070-y |
Ejemplares similares
-
Inhibition of DYRK1A proteolysis modifies its kinase specificity and rescues Alzheimer phenotype in APP/PS1 mice
por: Souchet, Benoît, et al.
Publicado: (2019) -
Is it time to rethink the Alzheimer's disease drug development strategy by targeting its silent phase?
por: Souchet, Benoit, et al.
Publicado: (2018) -
Adeno-Associated Virus-Based Gene Therapy for CNS Diseases
por: Hocquemiller, Michaël, et al.
Publicado: (2016) -
DM1 Transgenic Mice Exhibit Abnormal Neurotransmitter Homeostasis and Synaptic Plasticity in Association with RNA Foci and Mis-Splicing in the Hippocampus
por: Potier, Brigitte, et al.
Publicado: (2022) -
Genetically modified macrophages accelerate myelin repair
por: Aigrot, Marie‐Stéphane, et al.
Publicado: (2022)